ANNEXSupplementary provisions
ANNEX The entry corresponding to phoxim in Table 1 of the Annex to Regulation (EU) No 37/2010 is replaced by the following: Pharmacologically active substance Marker residue Animal Species MRL Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic classification ‘Phoxim Phoxim All food-producing species except fin fish. 25 μg/kg Muscle For porcine and poultry species the fat MRL relates to “skin and fat in natural proportions”. Not for use in animals from which milk is produced for human consumption. Antiparasitic agents/Agents against ectoparasites.’ 550 μg/kg Fat 50 μg/kg Liver 30 μg/kg Kidney 60 μg/kg Eggs